Open the Youtube video Biology has always been an unruly science. Cells divide when they want to. Genes switch on and off ...

Cancer therapy and synthetic biology are converging around a shared problem that has long frustrated oncologists and ...

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--bit.bio, a synthetic biology company focused on human cells, has achieved a milestone in the manufacture of human cells. Based on their opti-ox TM 1 - ...

Researchers released a consensus statement with recommendations to update T cell nomenclature and improve communication ...

Generation Bio announces new programs using ctLNP for targeted siRNA delivery in T cell-driven autoimmune diseases, aiming for IND submission in 2026. Development of novel siRNA therapeutics using ...

The FDA approval of denileukin diftitox (Lymphir) marked a significant shift in this paradigm. As a first-in-class immunotoxin, it employs a dual-action mechanism: directly targeting interleukin-2 (IL ...

Cell therapies are already here, with treatments now available for some cancers and rare diseases. But bringing such living medicines to more patients presents both scientific and financial challenges ...

Adicet Bio is handing out pink slips to 30% of its staffers in tandem with a pipeline restructure that includes discontinuing a clinical-stage allogeneic cell therapy. The layoffs are expected to be ...

Researchers have determined that condensates are electrically charged droplets that can induce voltage changes across the ...

From the generation of embryo-like structures to the establishment of cell-based approaches to model or treat disease, the field of stem cell and developmental biology has impressively progressed ...

Bio X Cell, the global leader of functional antibodies for in vivo and emerging preclinical models, unveils a refreshed brand identity which bridges nearly 30 years of scientific leadership in the ...